메뉴 건너뛰기




Volumn 10, Issue 4, 2015, Pages

Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. International CLARIFY registry

(2,547)  Fauchier, Laurent a   Greenlaw, Nicola b   Ferrari, Roberto c   Ford, Ian b   Fox, Kim M d   Tardif, Jean Claude e   Tendera, Michal f   Steg, Ph Gabriel d,g,h,i   Sokn, Fernando José j   Reid, Christopher j   Lang, Irene j   Van den Branden, Frank j   César, Luis Machado j   Mattos, Marco Antonio j   Nazar Luqman, Hj j   Goudev, Assen j   Dorian, Paul j   Hu, Dayi j   Widimsky, Petr j   Hassager, Christian j   more..


Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; THIENOPYRIDINE DERIVATIVE;

EID: 84928555753     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0125164     Document Type: Article
Times cited : (20)

References (29)
  • 1
    • 77957699729 scopus 로고    scopus 로고
    • Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
    • European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, PMID: 20802247
    • European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GY, Schotten U, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010; 31: 2369–2429. doi: 10.1093/eurheartj/ehq278 PMID: 20802247
    • (2010) Eur Heart J , vol.31 , pp. 2369-2429
    • Camm, A.J.1    Kirchhof, P.2    Lip, G.Y.3    Schotten, U.4
  • 2
    • 77958128969 scopus 로고    scopus 로고
    • Guidelines on myocardial revascularization
    • Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), European Association for Percutaneous Cardiovascular Interventions (EAPCI), PMID: 20802248
    • Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), European Association for Percutaneous Cardiovascular Interventions (EAPCI), Wijns W, Kolh P, Danchin N, Di Mario C, et al. Guidelines on myocardial revascularization. Eur Heart J. 2010; 31: 2501–2555. doi: 10.1093/eurheartj/ehq277 PMID: 20802248
    • (2010) Eur Heart J , vol.31 , pp. 2501-2555
    • Wijns, W.1    Kolh, P.2    Danchin, N.3    Di Mario, C.4
  • 3
    • 71749087343 scopus 로고    scopus 로고
    • Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: A retrospective analysis of nationwide registry data
    • PMID: 20006130
    • Sorensen R, Hansen ML, Abildstrom SZ, Hvelplund A, Andersson C, Jorgensen C, et al. Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data. Lancet. 2009; 374: 1967–1974. doi: 10.1016/S0140-6736(09)61751-7 PMID: 20006130
    • (2009) Lancet , vol.374 , pp. 1967-1974
    • Sorensen, R.1    Hansen, M.L.2    Abildstrom, S.Z.3    Hvelplund, A.4    Ersson, C.5    Jorgensen, C.6
  • 4
    • 84869146976 scopus 로고    scopus 로고
    • Women and men with stable coronary artery disease have similar clinical outcomes: Insights from the international prospective CLARIFY registry
    • PMID: 22922505
    • Steg PG, Greenlaw N, Tardif JC, Tendera M, Ford I, Kaab S, et al. Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry. Eur Heart J. 2012; 33: 2831–2840. doi: 10.1093/eurheartj/ehs289 PMID: 22922505
    • (2012) Eur Heart J , vol.33 , pp. 2831-2840
    • Steg, P.G.1    Greenlaw, N.2    Tardif, J.C.3    Tendera, M.4    Ford, I.5    Kaab, S.6
  • 5
    • 76749163232 scopus 로고    scopus 로고
    • Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The euro heart survey on atrial fibrillation
    • PMID: 19762550
    • Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010; 137: 263–272. doi: 10.1378/chest.09-1584 PMID: 19762550
    • (2010) Chest , vol.137 , pp. 263-272
    • Lip, G.Y.1    Nieuwlaat, R.2    Pisters, R.3    Lane, D.A.4    Crijns, H.J.5
  • 6
    • 77955872745 scopus 로고    scopus 로고
    • A novel user-friendly score (HASBLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The Euro Heart Survey
    • PMID: 20299623
    • Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HASBLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010; 138: 1093–1100. doi: 10.1378/chest.10-0134 PMID: 20299623
    • (2010) Chest , vol.138 , pp. 1093-1100
    • Pisters, R.1    Lane, D.A.2    Nieuwlaat, R.3    De Vos, C.B.4    Crijns, H.J.5    Lip, G.Y.6
  • 7
    • 54949116895 scopus 로고    scopus 로고
    • Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis
    • PMID: 19061698
    • Goto S, Bhatt DL, Rother J, Alberts M, Hill MD, Ikeda Y, et al. Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis. Am Heart J. 2008; 156: 855–863, 863 e852. doi: 10.1016/j.ahj.2008.06.029 PMID: 19061698
    • (2008) Am Heart J , vol.156
    • Goto, S.1    Bhatt, D.L.2    Rother, J.3    Alberts, M.4    Hill, M.D.5    Ikeda, Y.6
  • 8
    • 39149105940 scopus 로고    scopus 로고
    • Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis
    • PMID: 18294566
    • Ruiz-Nodar JM, Marin F, Hurtado JA, Valencia J, Pinar E, Pineda J, et al. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis. J Am Coll Cardiol. 2008; 51: 818–825. doi: 10.1016/j.jacc.2007.11.035 PMID: 18294566
    • (2008) J am Coll Cardiol , vol.51 , pp. 818-825
    • Ruiz-Nodar, J.M.1    Marin, F.2    Hurtado, J.A.3    Valencia, J.4    Pinar, E.5    Pineda, J.6
  • 9
    • 79955876172 scopus 로고    scopus 로고
    • Coronary stent implantation in patients committed to longterm oral anticoagulation therapy: Successfully navigating the treatment options
    • PMID: 21540213
    • Rubboli A, Kovacic JC, Mehran R, Lip GY. Coronary stent implantation in patients committed to longterm oral anticoagulation therapy: successfully navigating the treatment options. Chest. 2011; 139: 981–987. doi: 10.1378/chest.10-2719 PMID: 21540213
    • (2011) Chest , vol.139 , pp. 981-987
    • Rubboli, A.1    Kovacic, J.C.2    Mehran, R.3    Lip, G.Y.4
  • 10
    • 77950680872 scopus 로고    scopus 로고
    • Comparison of different antithrombotic regimens for patients with atrial fibrillation undergoing drug-eluting stent implantation
    • PMID: 20208381
    • Gao F, Zhou YJ, Wang ZJ, Shen H, Liu XL, Nie B, et al. Comparison of different antithrombotic regimens for patients with atrial fibrillation undergoing drug-eluting stent implantation. Circ J. 2010; 74: 701–708. PMID: 20208381
    • (2010) Circ J , vol.74 , pp. 701-708
    • Gao, F.1    Zhou, Y.J.2    Wang, Z.J.3    Shen, H.4    Liu, X.L.5    Nie, B.6
  • 11
    • 79551592248 scopus 로고    scopus 로고
    • Triple therapy rather than “triple threat”: A meta-analysis of the two antithrombotic regimens after stent implantation in patients receiving long-term oral anticoagulant treatment
    • PMID: 21285053
    • Zhao HJ, Zheng ZT, Wang ZH, Li SH, Zhang Y, Zhong M, et al. “Triple therapy” rather than “triple threat”: a meta-analysis of the two antithrombotic regimens after stent implantation in patients receiving long-term oral anticoagulant treatment. Chest. 2011; 139: 260–270. doi: 10.1378/chest.09-3083 PMID: 21285053
    • (2011) Chest , vol.139 , pp. 260-270
    • Zhao, H.J.1    Zheng, Z.T.2    Wang, Z.H.3    Li, S.H.4    Zhang, Y.5    Zhong, M.6
  • 12
    • 84875720372 scopus 로고    scopus 로고
    • Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: An open-label, randomised, controlled trial
    • PMID: 23415013
    • Dewilde WJ, Oirbans T, Verheugt FW, Kelder JC, De Smet BJ, Herrman JP, et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet. 2013; 381: 1107–1115. doi: 10.1016/S0140-6736(12)62177-1 PMID: 23415013
    • (2013) Lancet , vol.381 , pp. 1107-1115
    • Dewilde, W.J.1    Oirbans, T.2    Verheugt, F.W.3    Kelder, J.C.4    De Smet, B.J.5    Herrman, J.P.6
  • 13
    • 84865224357 scopus 로고    scopus 로고
    • Clinical outcome of stable outpatients with coronary, cerebrovascular or peripheral artery disease, and atrial fibrillation
    • PMID: 22658293
    • Aguilar E, Garcia-Diaz AM, Sanchez Munoz-Torrero JF, Alvarez LR, Piedecausa M, Arnedo G, et al. Clinical outcome of stable outpatients with coronary, cerebrovascular or peripheral artery disease, and atrial fibrillation. Thromb Res. 2012; 130: 390–395. PMID: 22658293
    • (2012) Thromb Res , vol.130 , pp. 390-395
    • Aguilar, E.1    Garcia-Diaz, A.M.2    Sanchez Munoz-Torrero, J.F.3    Alvarez, L.R.4    Piedecausa, M.5    Arnedo, G.6
  • 14
    • 84882258086 scopus 로고    scopus 로고
    • Antithrombotic therapy for patients with atrial fibrillation and atherothrombotic vascular disease: Striking the right balance between efficacy and safety
    • PMID: 23861513
    • Patrono C, Andreotti F. Antithrombotic therapy for patients with atrial fibrillation and atherothrombotic vascular disease: striking the right balance between efficacy and safety. Circulation. 2013; 128: 684–686. doi: 10.1161/CIRCULATIONAHA.113.004564 PMID: 23861513
    • (2013) Circulation , vol.128 , pp. 684-686
    • Patrono, C.1    Reotti, F.2
  • 15
    • 34249682101 scopus 로고    scopus 로고
    • Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation
    • PMID: 17540203
    • Nieuwlaat R, Olsson SB, Lip GY, Camm AJ, Breithardt G, Capucci A, et al. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation. Am Heart J. 2007; 153: 1006–1012. PMID: 17540203
    • (2007) Am Heart J , vol.153 , pp. 1006-1012
    • Nieuwlaat, R.1    Olsson, S.B.2    Lip, G.Y.3    Camm, A.J.4    Breithardt, G.5    Capucci, A.6
  • 16
    • 27444435844 scopus 로고    scopus 로고
    • Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation
    • NABOR Steering Committee, PMID: 16256877
    • Waldo AL, Becker RC, Tapson VF, Colgan KJ, NABOR Steering Committee. Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. J Am Coll Cardiol. 2005; 46: 1729–1736. PMID: 16256877
    • (2005) J am Coll Cardiol , vol.46 , pp. 1729-1736
    • Waldo, A.L.1    Becker, R.C.2    Tapson, V.F.3    Colgan, K.J.4
  • 17
    • 80053508197 scopus 로고    scopus 로고
    • Prognosis and guideline-adherent antithrombotic treatment in patients with atrial fibrillation and atrial flutter: Implications of undertreatment and overtreatment in real-life clinical practice; the Loire Valley Atrial Fibrillation Project
    • PMID: 21436246
    • Gorin L, Fauchier L, Nonin E, Charbonnier B, Babuty D, Lip GY. Prognosis and guideline-adherent antithrombotic treatment in patients with atrial fibrillation and atrial flutter: implications of undertreatment and overtreatment in real-life clinical practice; the Loire Valley Atrial Fibrillation Project. Chest. 2011; 140: 911–917. doi: 10.1378/chest.10-2436 PMID: 21436246
    • (2011) Chest , vol.140 , pp. 911-917
    • Gorin, L.1    Fauchier, L.2    Nonin, E.3    Charbonnier, B.4    Babuty, D.5    Lip, G.Y.6
  • 18
    • 0030046318 scopus 로고    scopus 로고
    • Physician variation in the management of patients with atrial fibrillation
    • PMID: 8673762
    • Lip GY, Zarifis J, Watson RD, Beevers DG. Physician variation in the management of patients with atrial fibrillation. Heart. 1996; 75: 200–205. PMID: 8673762
    • (1996) Heart , vol.75 , pp. 200-205
    • Lip, G.Y.1    Zarifis, J.2    Watson, R.D.3    Beevers, D.G.4
  • 19
    • 0037817710 scopus 로고    scopus 로고
    • Anticoagulant-related bleeding in older persons with atrial fibrillation: Physicians' fears often unfounded
    • PMID: 12860581
    • Man-Son-Hing M, Laupacis A. Anticoagulant-related bleeding in older persons with atrial fibrillation: physicians' fears often unfounded. Arch Intern Med. 2003; 163: 1580–1586. PMID: 12860581
    • (2003) Arch Intern Med , vol.163 , pp. 1580-1586
    • Man-Son-Hing, M.1    Laupacis, A.2
  • 20
    • 0036968487 scopus 로고    scopus 로고
    • Doctors' beliefs on the use of antithrombotic therapy in atrial fibrillation: Identifying barriers to stroke prevention
    • PMID: 11783668
    • Peterson GM, Boom K, Jackson SL, Vial JH. Doctors' beliefs on the use of antithrombotic therapy in atrial fibrillation: identifying barriers to stroke prevention. Intern Med J. 2002; 32: 15–23. PMID: 11783668
    • (2002) Intern Med J , vol.32 , pp. 15-23
    • Peterson, G.M.1    Boom, K.2    Jackson, S.L.3    Vial, J.H.4
  • 21
    • 77956411785 scopus 로고    scopus 로고
    • Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: Insights from ACTIVE-W
    • PMID: 20685676
    • De Caterina R, Connolly SJ, Pogue J, Chrolavicius S, Budaj A, Morais J, et al. Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-W. Eur Heart J. 2010; 31: 2133–2140. doi: 10.1093/eurheartj/ehq250 PMID: 20685676
    • (2010) Eur Heart J , vol.31 , pp. 2133-2140
    • De Caterina, R.1    Connolly, S.J.2    Pogue, J.3    Chrolavicius, S.4    Budaj, A.5    Morais, J.6
  • 22
    • 74249099911 scopus 로고    scopus 로고
    • Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting
    • PMID: 20062939
    • Lip GY, Huber K, Andreotti F, Arnesen H, Airaksinen KJ, Cuisset T, et al. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting. Thromb Haemost. 2010; 103: 13–28. doi: 10.1160/TH09-08-0580 PMID: 20062939
    • (2010) Thromb Haemost , vol.103 , pp. 13-28
    • Lip, G.Y.1    Huber, K.2    Reotti, F.3    Arnesen, H.4    Airaksinen, K.J.5    Cuisset, T.6
  • 23
    • 33744945247 scopus 로고    scopus 로고
    • Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): A randomised controlled trial
    • ACTIVE Writing Group of the ACTIVE Investigators, PMID: 16765759
    • ACTIVE Writing Group of the ACTIVE Investigators, Connolly S, Pogue J, Hart R, Pfeffer M, Hohnloser S, et al. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet. 2006; 367: 1903–1912. PMID: 16765759
    • (2006) Lancet , vol.367 , pp. 1903-1912
    • Connolly, S.1    Pogue, J.2    Hart, R.3    Pfeffer, M.4    Hohnloser, S.5
  • 24
    • 80053177375 scopus 로고    scopus 로고
    • Consensus document: Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspective
    • PMID: 21785808
    • Faxon DP, Eikelboom JW, Berger PB, Holmes DR, Bhatt DL, Moliterno DJ, et al. Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspective. Thromb Haemost. 2011; 106: 572–584. doi: 10.1160/TH11-04-0262 PMID: 21785808
    • (2011) Thromb Haemost , vol.106 , pp. 572-584
    • Faxon, D.P.1    Eikelboom, J.W.2    Berger, P.B.3    Holmes, D.R.4    Bhatt, D.L.5    Moliterno, D.J.6
  • 25
    • 80053207003 scopus 로고    scopus 로고
    • Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: Similarities and dissimilarities between North America and Europe
    • PMID: 21909592
    • Huber K, Airaksinen KJ, Cuisset T, Marin F, Rubboli A, Lip GY. Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: similarities and dissimilarities between North America and Europe. Thromb Haemost. 2011; 106: 569–571. doi: 10.1160/TH11-08-0602 PMID: 21909592
    • (2011) Thromb Haemost , vol.106 , pp. 569-571
    • Huber, K.1    Airaksinen, K.J.2    Cuisset, T.3    Marin, F.4    Rubboli, A.5    Lip, G.Y.6
  • 26
    • 6944237687 scopus 로고    scopus 로고
    • Late thrombosis in drugeluting coronary stents after discontinuation of antiplatelet therapy
    • PMID: 15500897
    • McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, et al. Late thrombosis in drugeluting coronary stents after discontinuation of antiplatelet therapy. Lancet. 2004; 364: 1519–1521. PMID: 15500897
    • (2004) Lancet , vol.364 , pp. 1519-1521
    • McFadden, E.P.1    Stabile, E.2    Regar, E.3    Cheneau, E.4    Ong, A.T.5    Kinnaird, T.6
  • 27
    • 84908220640 scopus 로고    scopus 로고
    • AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society
    • January CT, Wann LS, Alpert JS, Calkins H, Cleveland JC Jr., Cigarroa JE, et al. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014.
    • (2014) J am Coll Cardiol , pp. 2014
    • January, C.T.1    Wann, L.S.2    Alpert, J.S.3    Calkins, H.4    Cleveland, J.C.5    Cigarroa, J.E.6
  • 28
    • 84859603846 scopus 로고    scopus 로고
    • New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper
    • PMID: 22497820
    • De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, et al. New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper. J Am Coll Cardiol. 2012; 59: 1413–1425. doi: 10.1016/j.jacc.2012.02.008 PMID: 22497820
    • (2012) J am Coll Cardiol , vol.59 , pp. 1413-1425
    • De Caterina, R.1    Husted, S.2    Wallentin, L.3    Reotti, F.4    Arnesen, H.5    Bachmann, F.6
  • 29
    • 84863142762 scopus 로고    scopus 로고
    • Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial
    • PMID: 22215856
    • Hohnloser SH, Oldgren J, Yang S, Wallentin L, Ezekowitz M, Reilly P, et al. Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial. Circulation. 2012; 125: 669–676. doi: 10.1161/CIRCULATIONAHA.111.055970 PMID: 22215856
    • (2012) Circulation , vol.125 , pp. 669-676
    • Hohnloser, S.H.1    Oldgren, J.2    Yang, S.3    Wallentin, L.4    Ezekowitz, M.5    Reilly, P.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.